| scholarly article | Q13442814 |
| P50 | author | Gordon J. Freeman | Q27088375 |
| P2093 | author name string | Scott S | |
| Fanslow WC | |||
| McAdam AJ | |||
| Calderhead DM | |||
| Buhlmann JE | |||
| Greenfield EA | |||
| Sharpe AH | |||
| Lupher ML Jr | |||
| Chen AI | |||
| Baum PR | |||
| P2860 | cites work | Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells | Q24317763 |
| Identification of a human OX-40 ligand, a costimulator of CD4+ T cells with homology to tumor necrosis factor | Q24319938 | ||
| Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34 | Q24568305 | ||
| Continuous cultures of fused cells secreting antibody of predefined specificity | Q26776979 | ||
| Dendritic cells and the control of immunity | Q27860918 | ||
| T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production | Q28378845 | ||
| CD4 T cell cytokine differentiation: the B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1 | Q28508535 | ||
| Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts | Q28573846 | ||
| OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 | ||
| A two-step, two-signal model for the primary activation of precursor helper T cells | Q34797521 | ||
| The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response | Q36365985 | ||
| The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells | Q36366597 | ||
| Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified | Q36367631 | ||
| The route of antigen entry determines the requirement for L-selectin during immune responses | Q36377474 | ||
| Molecular cloning and characterization of a novel glycoprotein, gp34, that is specifically induced by the human T-cell leukemia virus type I transactivator p40tax | Q36958543 | ||
| B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. | Q37557689 | ||
| Tolerance or hypersensitivity to 2,4-dinitro-1-fluorobenzene: the role of Langerhans cell density within epidermis | Q38524663 | ||
| Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 | ||
| The OX-40 receptor provides a potent co-stimulatory signal capable of inducing encephalitogenicity in myelin-specific CD4+ T cells | Q41035761 | ||
| Hyporesponsiveness in contact hypersensitivity and irritant contact dermatitis in CD4 gene targeted mouse. | Q52519314 | ||
| CD40 and its crucial role as a member of the TNFR family. | Q52532699 | ||
| B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation | Q56908531 | ||
| Properties of mouse CD40: Cellular distribution of CD40 and B cell activation by monoclonal anti-mouse CD40 antibodies | Q56964552 | ||
| Selective depletion of myelin-reactive T cells with the anti-OX-40 antibody ameliorates autoimmune encephalomyelitis | Q70934403 | ||
| Major histocompatibility complex class I-restricted CD8+ T cells and class II-restricted CD4+ T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene | Q71564536 | ||
| A simple and effective method to assess murine delayed type hypersensitivity to proteins | Q72647481 | ||
| Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity | Q74181214 | ||
| Distinct roles for B7 costimulation in contact hypersensitivity and humoral immune responses to epicutaneous antigen | Q77715005 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 689-698 | |
| P577 | publication date | 1999-12-01 | |
| P1433 | published in | Immunity | Q6005457 |
| P1476 | title | Ox40-ligand has a critical costimulatory role in dendritic cell:T cell interactions | |
| P478 | volume | 11 |
| Q24291798 | A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells |
| Q40404804 | A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells |
| Q34087699 | A novel helper role for CD4 T cells |
| Q54768658 | A recombinant vector expressing transgenes for four T-cell costimulatory molecules (OX40L, B7-1, ICAM-1, LFA-3) induces sustained CD4+ and CD8+ T-cell activation, protection from apoptosis, and enhanced cytokine production. |
| Q38737500 | ATVB Distinguished Scientist Award: How Costimulatory and Coinhibitory Pathways Shape Atherosclerosis |
| Q34358363 | Activation of OX40 Augments Th17 Cytokine Expression and Antigen-Specific Uveitis |
| Q39161011 | Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy |
| Q34582700 | Antigen-independent signalosome of CARMA1, PKCθ, and TNF receptor-associated factor 2 (TRAF2) determines NF-κB signaling in T cells |
| Q44158655 | Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses |
| Q34038749 | Antitumor vaccination using peptide based vaccines. |
| Q36604795 | Approaches to studying costimulation of human antiviral T cell responses: prospects for immunotherapeutic vaccines |
| Q37350842 | Association of the co-stimulator OX40L with systemic lupus erythematosus |
| Q38619261 | B cell OX40L supports T follicular helper cell development and contributes to SLE pathogenesis |
| Q34712635 | Balancing protective immunity and immunopathology |
| Q82542679 | Blockade of OX40-ligand after initial triggering of the T helper 2 response inhibits mercuric chloride-induced autoimmunity |
| Q90348119 | Blockade of OX40/OX40L pathway combined with ethylene-carbodiimide-fixed donor splenocytes induces donor-specific allograft tolerance in presensitized recipients |
| Q36251308 | Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD). |
| Q33924191 | CD27 is required for generation and long-term maintenance of T cell immunity |
| Q79075177 | CD27/CD70, CD134/CD134 ligand, and CD30/CD153 pathways are independently essential for generation of regulatory cells after intratracheal delivery of alloantigen |
| Q36013773 | CD28-independent induction of experimental autoimmune encephalomyelitis |
| Q52007792 | CD4(+)CD3(-) accessory cells costimulate primed CD4 T cells through OX40 and CD30 at sites where T cells collaborate with B cells. |
| Q36380502 | CD4+CD3- cells regulate the organization of lymphoid tissue and T-cell memory for antibody responses |
| Q34390710 | CD8+ T cell migration to the skin requires CD4+ help in a murine model of contact hypersensitivity |
| Q24806926 | Cell fate decision: T-helper 1 and 2 subsets in immune responses |
| Q40124936 | Co-immunisation with DNA encoding RANK/RANKL or 4-1BBL costimulatory molecules does not enhance effector or memory CTL responses afforded by immunisation with a tumour antigen-encoding DNA vaccine |
| Q33953188 | Co-stimulation and selection for T-cell help for germinal centres: the role of CD28 and OX40. |
| Q28207052 | Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? |
| Q36360561 | Co-stimulatory molecules as potential targets for therapeutic intervention in allergic airway disease |
| Q34582640 | Combinations of immunotherapy and radiation in cancer therapy. |
| Q47952891 | Combined OX40L and mTOR blockade controls effector T cell activation while preserving Treg reconstitution after transplant |
| Q28511040 | Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNgamma-mediated B cell depletion |
| Q58461878 | Contribution of CD30/CD153 but not of CD27/CD70, CD134/OX40L, or CD137/4-1BBL to the optimal induction of protective immunity toMycobacterium avium |
| Q33899607 | Control of immunity by the TNFR-related molecule OX40 (CD134) |
| Q33971036 | Costimulation in antiviral immunity: differential requirements for CD4(+) and CD8(+) T cell responses |
| Q35145627 | Costimulation of T cells by OX40, 4-1BB, and CD27. |
| Q37685171 | Costimulation signals for memory CD8+ T cells during viral infections |
| Q56903901 | Costimulation through OX40 is crucial for induction of an alloreactive human T-cell response |
| Q36370731 | Costimulation via OX40L expressed by B cells is sufficient to determine the extent of primary CD4 cell expansion and Th2 cytokine secretion in vivo |
| Q37314799 | Critical Role of Transcription Factor PU.1 in the Function of the OX40L/TNFSF4 Promoter in Dendritic Cells |
| Q46091534 | DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming |
| Q35988802 | Dendritic cell-mediated T cell polarization |
| Q36376225 | Development of allergic inflammation in a murine model of asthma is dependent on the costimulatory receptor OX40. |
| Q55456683 | Development of third generation anti-EGFRvIII chimeric T cells and EGFRvIII-expressing artificial antigen presenting cells for adoptive cell therapy for glioma. |
| Q40539049 | Dietary selenium modulates activation and differentiation of CD4+ T cells in mice through a mechanism involving cellular free thiols |
| Q40774919 | Distinct mRNA microarray profiles of tolerogenic dendritic cells |
| Q34632071 | Effector and memory T-cell differentiation: implications for vaccine development |
| Q37617470 | Effector and regulatory mechanisms in allergic contact dermatitis. |
| Q90686044 | Emerging strategies for combination checkpoint modulators in cancer immunotherapy |
| Q28210874 | Enhanced CD4+ T cell proliferation and Th2 cytokine production in DR6-deficient mice |
| Q40628569 | Enhanced Effector and Memory CTL Responses Generated by Incorporation of Receptor Activator of NF-κB (RANK)/RANK Ligand Costimulatory Molecules into Dendritic Cell Immunogens Expressing a Human Tumor-Specific Antigen |
| Q47683735 | Essential role of OX40L on B cells in persistent alloantibody production following repeated alloimmunizations |
| Q36369156 | Essential role of lymph nodes in contact hypersensitivity revealed in lymphotoxin-alpha-deficient mice. |
| Q46860994 | Expression of OX40 (CD134) on CD4+ T-cells from patients with myasthenia gravis |
| Q40807021 | Expression of gp34 (OX40 ligand) and OX40 on human T cell clones |
| Q38001203 | Fine-tuning of dendritic cell biology by the TNF superfamily |
| Q40327786 | Functional and transcriptional profiling of MUTZ-3, a myeloid cell line acting as a model for dendritic cells |
| Q36155114 | Genetic and genomic insights into the molecular basis of atherosclerosis |
| Q41811366 | Human monocyte-derived dendritic cells induce naive T cell differentiation into T helper cell type 2 (Th2) or Th1/Th2 effectors. Role of stimulator/responder ratio |
| Q34075628 | Human vascular smooth muscle cells lack essential costimulatory molecules to activate allogeneic memory T cells |
| Q43805219 | IL-1 alpha, but not IL-1 beta, is required for contact-allergen-specific T cell activation during the sensitization phase in contact hypersensitivity |
| Q91559991 | ILC3-derived OX40L is essential for homeostasis of intestinal Tregs in immunodeficient mice |
| Q57296151 | Identification of a Novel OX40L Dendritic Cell Subset That Selectively Expands Regulatory T cells |
| Q37965921 | Immunological mechanisms of contact hypersensitivity in mice |
| Q38091675 | Immunotherapy for the management of advanced melanoma: the next steps |
| Q90458905 | In vitro model for the assessment of human immune responses to subunit RSV vaccines |
| Q36173559 | In vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammation |
| Q33942185 | In vivo maturation and migration of dendritic cells |
| Q28072532 | Is There Still Room for Cancer Vaccines at the Era of Checkpoint Inhibitors |
| Q34572115 | Knockout mice: a paradigm shift in modern immunology |
| Q47287396 | Lentiviral gp34/OX40L gene transfer into dendritic cells facilitates alloreactive CD4+ T-cell response in vitro |
| Q61863498 | Lethal T cell immunodeficiency induced by chronic costimulation via CD27-CD70 interactions |
| Q56904986 | Manipulation of costimulatory pathways in autoimmune diseases |
| Q34265779 | Mini‐review: Regulation of cytotoxic T lymphocyte responses by dendritic cells: peaceful coexistence of cross‐priming and direct priming? |
| Q38093572 | Modulation of tumor immunity by soluble and membrane-bound molecules at the immunological synapse. |
| Q38090202 | Natural killer cells: walking three paths down memory lane |
| Q94552595 | New pathways in immune stimulation: targeting OX40 |
| Q38108836 | Novel antibodies targeting immune regulatory checkpoints for cancer therapy. |
| Q36371325 | OX40 (CD134) controls memory T helper 2 cells that drive lung inflammation |
| Q82847888 | OX40 (CD134) engagement drives differentiation of CD4+ T cells to effector cells |
| Q42060017 | OX40 costimulation by a chimeric antigen receptor abrogates CD28 and IL-2 induced IL-10 secretion by redirected CD4(+) T cells |
| Q36007580 | OX40 costimulation turns off Foxp3+ Tregs. |
| Q37311042 | OX40 drives protective vaccinia virus-specific CD8 T cells |
| Q36099421 | OX40 ligand expressed by DCs costimulates NKT and CD4+ Th cell antitumor immunity in mice |
| Q36707135 | OX40 ligand expression abrogates the immunosuppressive function of retinal pigment epithelium |
| Q28188488 | OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells |
| Q40692273 | OX40 signaling renders adult T-cell leukemia cells resistant to Fas-induced apoptosis |
| Q37761492 | OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology. |
| Q41849418 | OX40-OX40L interactions: a promising therapeutic target for allergic diseases? |
| Q35077583 | Opposing effects of CD70 costimulation during acute and chronic lymphocytic choriomeningitis virus infection of mice |
| Q34313811 | Phenotypic characterization of regulatory T cells in the human decidua. |
| Q34293431 | Phenotypic characterization of subsets of T cell lymphoma: towards a functional classification of T cell lymphoma |
| Q44150677 | Pimecrolimus inhibits up-regulation of OX40 and synthesis of inflammatory cytokines upon secondary T cell activation by allogeneic dendritic cells |
| Q24317518 | Prostaglandin E(2) enhances T-cell proliferation by inducing the costimulatory molecules OX40L, CD70, and 4-1BBL on dendritic cells |
| Q44436559 | Prostaglandin E2-EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells. |
| Q34353313 | Pulmonary immunity to viral infection: adenovirus infection of lung dendritic cells renders T cells nonresponsive to interleukin-2 |
| Q41992239 | Reciprocal activating interaction between natural killer cells and dendritic cells |
| Q90927802 | Reciprocal changes in CD11c+CD11b+ and CD11c+CD8α+ dendritic cell subsets determine protective or permissive immune response in murine experimental VL |
| Q81610382 | Regulation of OX40 gene expression in graft-versus-host disease |
| Q35884198 | Requirements for the development of IL-4-producing T cells during intestinal nematode infections: what it takes to make a Th2 cell in vivo |
| Q48036263 | Retroviral transduction of acute myeloid leukaemia-derived dendritic cells with OX40 ligand augments their antigen presenting activity |
| Q26800155 | Role of Tumor Necrosis Factor Superfamily in Neuroinflammation and Autoimmunity |
| Q34830578 | Roles of IL-1 in the development of rheumatoid arthritis: consideration from mouse models |
| Q36380507 | Roles of OX40 in the pathogenesis and the control of diseases |
| Q27022436 | Science gone translational: the OX40 agonist story |
| Q46036396 | Signaling through OX40 (CD134) breaks peripheral T-cell tolerance. |
| Q37682640 | Signals that influence T follicular helper cell differentiation and function. |
| Q91584719 | Statins can suppress DC-mediated Th2 responses through the repression of OX40-ligand and CCL17 expression |
| Q55239751 | Suppression of autoimmune arthritis in interleukin-1-deficient mice in which T cell activation is impaired due to low levels of CD40 ligand and OX40 expression on T cells. |
| Q41895228 | T cell accumulation in B cell follicles is regulated by dendritic cells and is independent of B cell activation |
| Q36170783 | T cell costimulatory molecules in anti-viral immunity: Potential role in immunotherapeutic vaccines |
| Q37783748 | T follicular helper cells during immunity and tolerance. |
| Q34059260 | T lymphocyte costimulatory molecules in host defense and immunologic diseases |
| Q35608835 | T lymphocyte dependence of the antibody response to 'T lymphocyte independent type 2' antigens. |
| Q40347857 | T-cell co-stimulators as anti-inflammatory targets for atherosclerotic disease |
| Q38168010 | T-cell costimulatory blockade in organ transplantation |
| Q35583511 | T-cell costimulatory pathways in allograft rejection and tolerance |
| Q30743828 | TNF ligands and receptors in autoimmunity: an update |
| Q56905959 | The CD28-related molecule ICOS is required for effective T cell-dependent immune responses |
| Q38684474 | The Ox40/Ox40 Ligand Pathway Promotes Pathogenic Th Cell Responses, Plasmablast Accumulation, and Lupus Nephritis in NZB/W F1 Mice |
| Q34428899 | The TNFR family members OX40 and CD27 link viral virulence to protective T cell vaccines in mice |
| Q38081999 | The TNFRs OX40, 4-1BB, and CD40 as targets for cancer immunotherapy |
| Q51955521 | The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine. |
| Q34719084 | The role of TNF receptor and TNF superfamily molecules in organ transplantation |
| Q37604805 | The role of costimulatory molecules in allergic disease and asthma |
| Q34979946 | The significance of OX40 and OX40L to T-cell biology and immune disease. |
| Q35790354 | Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40. |
| Q34324978 | Towards the rational design of Th1 adjuvants |
| Q36380499 | Tumor necrosis factor/tumor necrosis factor receptor family members that positively regulate immunity |
| Q36202186 | Two sides of a cellular coin: CD4(+)CD3- cells regulate memory responses and lymph-node organization |
| Q45346306 | Upregulation of OX40 ligand on monocytes contributes to early virological control in patients with chronic hepatitis C. |
| Q36604777 | Why can't the immune system control HIV-1? Defining HIV-1-specific CD4+ T cell immunity in order to develop strategies to enhance viral immunity |
Search more.